The building evidence for the contribution of microbiota to human disease has spurred an
effort to develop therapies that target the gut microbiota. This is particularly evident in …

… Mitchell, and Thomas J. Borody designed the clinical trial. Sudarshan Paramsothy, Ramesh
Paramsothy, Alissa J. Walsh, Johan van den Bogaerde, Douglas Samuel, Rupert WL Leong, …

Background The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis.
Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its …

There has been growing interest in the use of fecal microbiota for the treatment of patients
with chronic gastrointestinal infections and inflammatory bowel diseases. Lately, there has …

Fecal microbiota transplantation (FMT), the core therapy for remodeling the gut microbiota
with a long medical history, has gained great attention worldwide in recent years. Increasing …

Fecal microbiota transplantation (FMT) has been utilized sporadically for over 50 years. In the
past few years, Clostridium difficile infection (CDI) epidemics in the USA and Europe have …

Background Although the etiology of idiopathic ulcerative colitis (UC) remains poorly
understood, the intestinal flora is suspected to play an important role. Specific, consistent …

The intestinal flora may play a key role in the pathogenesis of certain gastrointestinal (GI)
diseases. Components of bowel flora such as Lactobacillus acidophilus and Bifidobacterium …

Fecal microbiota transplantation (FMT) has attracted great interest in recent years, largely
due to the global Clostridium difficile infection (CDI) epidemic and major advances in …

The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life-threatening …